All of the aforementioned genes, namely EPHA8, EFNB2, EPHA5, EPHB2, and EPHA4 (excepting EPHA7) are significantly overexpressed in metastatic disease in comparison with advanced non-metastatic disease. This evidence concerns the gene EPHA4 and metastatic neoplasm.